Ginsenoside Rg2 Ameliorates Alzheimer's Disease by Alleviating Neuroinflammation in APP/PS1 Mice
GRg2 improves cognitive function and mitigates AD pathology, which is at least partially attributed to its regulation of gut microbiota and metabolites, as well as its anti-neuroinflammatory effects.
Authors
- Yifa Zhou (ORCID: https://orcid.org/0000-0002-1917-2000)
- Jing Cui (ORCID: https://orcid.org/0000-0001-9264-5997)
- Yue Guan (ORCID: https://orcid.org/0000-0002-5977-6984)
- Qianqian Zhang (ORCID: https://orcid.org/0000-0003-3442-4461)
- Di Wang (ORCID: https://orcid.org/0000-0001-9293-9039)
- Zhiping Li (ORCID: https://orcid.org/0000-0003-1975-8447)
- Chunyue Wang (ORCID: https://orcid.org/0000-0002-7717-8494)
- Gong Wang
- Dilida Yeerkenbieke
Institutions
- Inner Mongolia University for Nationalities (CN)
- Northeast Normal University (CN)
- Jilin University (CN)
- Changchun Normal University (CN)
- Tongliao Academy of Agricultural Sciences (CN)
- First Hospital of Jilin University (CN)
- Jilin Agricultural University (CN)
Publication Details
- Journal
- Current Neuropharmacology
- Published
- 2025-09-26
- DOI
- https://doi.org/10.2174/011570159x395496250911104139
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00